RESUMEN
Objective:To study the diuretic effect of micronized powder of Panax notoginseng (Burk.) F.H.Chen on rats.Methods:The metabolic cage method and weighing method were used in this experiment;The indictor of urine excretion in 6 h was used to study the diuretic effect of powder ofPanax notoginseng (Burk.) F.H.Chen in the water loaded rats;the output of Na +,K +,C1-in urine were measured to elucidate the related mechanization.Results:Powder of Panax notoginseng (Burk.) F.H.Chen under high dose after administration of 2h to 5h can significantly increase the urine volume of rat compared with the blank control group (P＜0.01,P＜0.05),but no diuretic effect after administration of 6h.powder of Panax notoginseng (Burk.) F.H.Chen under high dose could increase the urine Na+,Cl-(P ＜0.01) but reduce the K+ excretion,inhibitting the Na+ reabsorption and K+ excretion of renal tubule.It could significantly increase rat urine pH value (P＜0.01),the effect ofpH value by which is similar with the effect of hydrochlorothiazide and the effect of Jinqiancao granules.Conclusion:For the first time,this study investigated the diuretic effect of powder of Panax notoginseng (Burk.) F.H.Chen,The relevant mechanism is that powder of Panax notoginseng (Burk.) F.H.Chen have an impact on inhibitting the Na+ reabsorption and K+ excretion of renal tubule.
RESUMEN
Objective: To investigate the hypolipidemic effects of powder of Panax notoginseng (PPN) and explore its possible mechanism. Methods: Hyperlipidemic rats model was established, and orally given three dosages of PPN for 8 weeks. The levels of serum ALT, AST, TC, TG, and LDL-C were detected. The pathological changes of liver tissues were observed by H&E staining. Gene expressions of hepatic low density lipoprotein receptor (LDLR), SIRT1, and LXR-α were measured with RT-PCR analysis. Protein expression of SREBP-2 and SCAP was determined by Western blotting. Results: Three dosages of PPN significantly decreased serum ALT, AST, TC, TG, and LDL-C levels. Histological data indicated that PPN notably reduced liver injury and hepatic steatosis in hyperlipidemic rats. In molecular study, mRNA expression of hepatic LDLR and SIRT1 was up-regulated and LXR-α gene expression was down-regulated in PPN treated rats. Additionally, PPN significantly reduced protein expression of SREBP-2 and SCAP. Conclusion: The positive effect of PPN on hyperlipidemic rats may be related to the inhibition of cholesterol synthesis of PPN through the up-regulation of SIRT1 and down-regulation of LXR-α and SCAP/SREBP-2 signaling pathway. Additionally, PPN could up-regulate hepatic LDLR mRNA expression and improve uptake of LDL-C in circulation.